Case Report: Rare pheochromocytoma in a patient with Li–Fraumeni syndrome: a 3-event, 4-hit model of pathogenesis
Li-Fraumeni syndrome (LFS) is a rare autosomal dominant hereditary cancer predisposition syndrome caused by germline <i>TP53</i> pathogenic variants. Despite numerous studies of associated cancers with this syndrome, cases of pheochromocytoma have not been well documented. We present a patient from an LFS family who developed a right adrenal mass with a clinical presentation consistent with a pheochromocytoma. Genetic studies of this tumor identified a germline <i>TP53</i> pathogenic variant (c.818G>A; p.Arg273His) with somatic loss of the wild-type allele (loss of heterozygosity, LOH). In addition, a likely somatic <i>NF1</i> pathogenic variant was found with concomitant LOH. There were no reported cases of pheochromocytoma in the family history. In addition, several bile duct adenomas (BDAs) were discovered and biopsied intraoperatively. Sequence analysis of one BDA revealed a likely somatic <i>FGFR2::FKR</i> pathogenic fusion and the identical germline <i>TP53</i> pathogenic variant. In contrast to the pheochromocytoma, the BDA showed no evidence of a second <i>TP53</i> alteration that might suggest that <i>TP53</i> had played a role in its pathogenesis. This case highlights the rare presentation of pheochromocytoma in LFS and provides a molecular hypothesis of how this tumor may have developed.
Authors
- Naris Nilubol (ORCID: https://orcid.org/0000-0002-7348-7804)
- Payal P. Khincha (ORCID: https://orcid.org/0000-0003-2473-7800)
- Aaron J Dinerman (ORCID: https://orcid.org/0009-0008-8670-8347)
- Ashley Grossman
- Kathleen Calzone
- Liqiang Xi
- Karel Pacak
- Mark Raffeld
- Yi Liu
- Kenneth Aldape
- Ina Lee
- Manoj Tyagi
Institutions
- National Institutes of Health (US)
- The Royal Free Hospital (GB)
- National Institute of Child Health (HU)
- National Cancer Institute (UA)
- National Cancer Institute (MY)
- Cancer Genetics (United States) (US)
- Center for Cancer Research (US)
- Health and Human Development (2HD) Research Network (CM)
- Department of Health and Human Services (US)
- University College London (GB)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-03-11
- DOI
- https://doi.org/10.3389/fonc.2026.1714565
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute